PDXliver: a database of liver cancer patient derived xenograft mouse models.

about

PDXliver: a database of liver cancer patient derived xenograft mouse models.

Item

http://www.wikidata.org/entity/Q53685286

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

PDXliver: a database of liver cancer patient derived xenograft mouse models.

@en

PDXliver: a database of liver cancer patient derived xenograft mouse models.

@nl

type

Item

label

PDXliver: a database of liver cancer patient derived xenograft mouse models.

@en

PDXliver: a database of liver cancer patient derived xenograft mouse models.

@nl

prefLabel

PDXliver: a database of liver cancer patient derived xenograft mouse models.

@en

PDXliver: a database of liver cancer patient derived xenograft mouse models.

@nl

P1476

PDXliver: a database of liver cancer patient derived xenograft mouse models.

@en

P2093

Bo Hu

http://www.w3.org/2001/XMLSchema#string

Chao Li

http://www.w3.org/2001/XMLSchema#string

Fang-You-Min Feng

http://www.w3.org/2001/XMLSchema#string

Hong Li

http://www.w3.org/2001/XMLSchema#string

Jia Fan

http://www.w3.org/2001/XMLSchema#string

Jia Li

http://www.w3.org/2001/XMLSchema#string

Jian Zhou

http://www.w3.org/2001/XMLSchema#string

Ping Lin

http://www.w3.org/2001/XMLSchema#string

Qian-Lan Yao

http://www.w3.org/2001/XMLSchema#string

Sheng He

http://www.w3.org/2001/XMLSchema#string

P2860

Patient-derived tumour xenografts as models for oncology drug development

Patient-derived tumor xenografts: transforming clinical samples into mouse models

Patient-derived xenograft models of breast cancer and their predictive power

Sorafenib in advanced hepatocellular carcinoma

Establishment and characterization of 7 novel hepatocellular carcinoma cell lines from patient-derived tumor xenografts

Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance.

A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer

Patient-derived xenografts for individualized care in advanced sarcoma.

Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study.

Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: a p53 Research Group study.

P2888

s12885-018-4459-6

P304

550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4459-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wei Guo

Yang Xu

P577

2018-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103901010

http://www.w3.org/2001/XMLSchema#string

P698

29743053

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

Base de dados

P932

5944069

http://www.w3.org/2001/XMLSchema#string